India's cumulative Covid-19 vaccination coverage exceeded the 1.96 bn mark on Saturday, informed the Ministry of Health and Family Welfare.
Over 121.4 mn balance and unutilized COVID-19 vaccine doses are still available with the States and UTs to be administered, informed the Ministry of Health and Family Welfare on Saturday
India started vaccinating adolescents (aged 15-18) from January, and further expanded the drive to include children as young as 12 years from March
While more than 7 million deaths were likely averted in countries covered by Covax, the WHO-backed distribution program, the research nonetheless highlights the devastation caused by uneven access
Denial of doses to persons without IDs, absence of segregated data and low awareness pose question mark on campaign
Fewer than 20% have taken precautionary vaccine dose, with Delhi, Mumbai and Bengaluru accounting for a quarter of the jabs taken by the 18-59 age group
About 375 million people over the age of 15 in China have yet to receive three doses of a vaccine, while the daily vaccination rate has fallen below 800,000 per day
Covid-19 vaccines prevented over 42 lakh potential deaths in India in 2021, said a study published in The Lancet Infectious Diseases journal
India reported 13,313 new cases in the last 24 hours and the active caseload currently stands at 83,990
The expert panel in its last meeting in April had sought more data from SII following its application seeking the emergency use authorization of Covovax for seven to 11 years
Biological E has received the WHO nod to be an additional facility for production of Johnson & Johnson COVID-19 vaccine. "Congratulations to @biological_e on its @WHO approval as an additional manufacturing site for the Janssen/Johnson & Johnson COVID-19 vaccine! Great progress for the Quad Vaccine and #USIndiaHealth partnerships through U.S. technical support and @DFCgov financing," the US embassy in India said in a tweet on Wednesday. India's first indigenously developed RBD protein subunit vaccine, Biological E's Corbevax, is currently being used to inoculate children in the age group of 12 to 14 years. The Drugs Controller General of India (DCGI) recently approved Corbevax as a precaution dose for those aged 18 and above.
India has added 86,128 cases in the past 7 days
The count of active cases across India on June 20 saw an increase of 2,613
However, experts say that Covaxin induces a wider immune response and thus antibody production against the spike protein may be less intense
According to the minister, India has a number of Covid vaccines and can help other developing countries to make vaccines
Union Health Minister Mansukh Mandaviya on Monday suggested G20 members for an institutional framework to enable rapid sharing of genome sequencing data along with a neutral & aggregate data-sharing model amongst countries.
So far, India has not allowed heterologous boosting of vaccines
Mumbai on Monday reported 1,310 fresh Covid-19 cases, a drop of 37 per cent compared to the previous day, and two fatalities, the city civic body said.
Commerce and industry minister Piyush Goyal on Monday said TRIPS waiver for five years agreed in the recently concluded WTO will help countries manufacture Covid vaccines to deal with the pandemic.
Myanmar has fully vaccinated more than 27.5 million people, or 50.18 per cent of the country's 54.8-million population, against Covid-19, according to its Ministry of Health.